Democrats remain at odds over how to design legislation to allow the government to negotiate for lower drug prices, a divide that may keep a solution out of their sweeping domestic policy package.
The White House omitted measures meant to lower drug prices from its framework for a $1.75 trillion domestic spending package released Thursday. There isn’t enough agreement among Democrats on drug price negotiation to include it in the framework, a Biden administration official told reporters Thursday.
Drug Price Negotiation Dropped in Proposed White House Plan
The fault lines were on display as lawmakers rush to reach a deal ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.